HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $441,000 | +20.5% | 24,252 | +11.9% | 0.01% | +22.2% |
Q2 2018 | $366,000 | -3.2% | 21,680 | +12.5% | 0.01% | -18.2% |
Q1 2018 | $378,000 | -2.8% | 19,272 | +0.3% | 0.01% | 0.0% |
Q4 2017 | $389,000 | -5.1% | 19,208 | -18.6% | 0.01% | -8.3% |
Q3 2017 | $410,000 | +4.3% | 23,607 | -22.9% | 0.01% | -7.7% |
Q2 2017 | $393,000 | -1.0% | 30,629 | +0.0% | 0.01% | 0.0% |
Q1 2017 | $397,000 | -2.5% | 30,628 | -25.6% | 0.01% | 0.0% |
Q4 2016 | $407,000 | +2.3% | 41,166 | +24.9% | 0.01% | +18.2% |
Q3 2016 | $398,000 | -8.3% | 32,970 | -34.4% | 0.01% | 0.0% |
Q2 2016 | $434,000 | -18.3% | 50,240 | -10.4% | 0.01% | -15.4% |
Q1 2016 | $531,000 | -12.7% | 56,100 | +59.8% | 0.01% | 0.0% |
Q4 2015 | $608,000 | +12.0% | 35,108 | -13.2% | 0.01% | +30.0% |
Q3 2015 | $543,000 | -42.8% | 40,441 | -3.9% | 0.01% | -28.6% |
Q2 2015 | $950,000 | +8.3% | 42,087 | -31.4% | 0.01% | +16.7% |
Q1 2015 | $877,000 | -0.2% | 61,389 | -32.6% | 0.01% | 0.0% |
Q4 2014 | $879,000 | +14.6% | 91,079 | +8.1% | 0.01% | +20.0% |
Q3 2014 | $767,000 | +0.7% | 84,283 | +9.2% | 0.01% | 0.0% |
Q2 2014 | $762,000 | -4.3% | 77,159 | +23.2% | 0.01% | 0.0% |
Q1 2014 | $796,000 | +49.3% | 62,650 | +76.3% | 0.01% | +42.9% |
Q4 2013 | $533,000 | +39.9% | 35,532 | +2.8% | 0.01% | +40.0% |
Q3 2013 | $381,000 | – | 34,555 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |